Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 12,657 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Period A Clear all

Conditions: Coronary Artery Disease, Plaque, Atherosclerotic
Interventions: Coronary intervention, Optimal Medical treatment; Device · Drug
Lead sponsor: Seung-Jung Park; Other
Eligibility: 18 Years and older
Enrollment: 1,608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcoholic Intoxication, Neurobehavioral Manifestations
Interventions: Alcohol, Placebo; Drug · Other
Lead sponsor: Boston University; Other
Eligibility: 21 Years to 30 Years
Enrollment: 239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Knee Osteoarthritis
Interventions: Hatha yoga, Aerobic and strengthening exercises, General education; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 60 Years to 100 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Neuropathy, Painful, Chemotherapy-induced Peripheral Neuropathy, Colorectal Cancer
Interventions: Lidocaine Hydrochloride, Placebo, FOLFOX regimen; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pregnancy, Obesity, Weight Gain, Obstetric Complications
Interventions: Lifestyle intervention; Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Post Traumatic Stress Disorders, Unsafe Sex, Substance Use Disorders
Interventions: Cognitive Processing Therapy-Cognitive; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Toppenish, Washington

Conditions: Diabetes Mellitus Type 2
Interventions: Placebo, RO5095932; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Acute Kidney Injury, Dialysis Hypotension
Interventions: ORKID Bundled Intervention, Furosemide; Other · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Coronary Microvascular Dysfunction
Interventions: Polyphenol-Rich Plant-Based Diet; Other
Lead sponsor: Emory University; Other
Eligibility: 45 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Alcohol Misuse, Homeless
Interventions: Smart-T Alcohol, Usual Care; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: HIV, Infectious
Interventions: darunavir, ritonavir; Drug
Lead sponsor: Tibotec, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 41
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 38 more

Conditions: Parkinson's Disease
Interventions: Levodopa (L-dopa); Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Low Back Pain
Interventions: Matched Physical Therapy Intervention, Current Care in Family Medicine; Other
Lead sponsor: University of Vermont Medical Center; Other
Eligibility: 21 Years to 60 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Retinal Detachment
Interventions: Dexmedetomidine infusion, propofol; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 70 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Newark, New Jersey

Conditions: Kidney Failure, Chronic, Kidney Transplantation, Immunosuppression
Interventions: Sirolimus, MMF or Azathioprine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 1 Year to 20 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 5
States / cities: Madera, California • San Francisco, California • Boston, Massachusetts + 2 more

Conditions: Gout
Interventions: Pegloticase, methotrexate, placebo, folic acid, gout flare prophylaxis regimen, fexofenadine, acetaminophen, methylprednisolone; Biological · Drug · Dietary Supplement
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 60
States / cities: Birmingham, Alabama • Anchorage, Alaska • Flagstaff, Arizona + 54 more

Conditions: Parkinson Disease, Autonomic Dysfunction, Depression
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: HLD200 methylphenidate hydrochloride (MPH) Capsules, Placebo; Drug
Lead sponsor: Ironshore Pharmaceuticals and Development, Inc; Other
Eligibility: 6 Years to 12 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 7
States / cities: Newport Beach, California • Bradenton, Florida • Maitland, Florida + 4 more

Conditions: Parkinson Disease (PD)
Interventions: Overactive bladder antimuscarinic deprescribing; Drug
Lead sponsor: Corporal Michael J. Crescenz VA Medical Center; Federal
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy Volunteers
Interventions: plazomicin, metformin; Drug
Lead sponsor: Achaogen, Inc.; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Hyperkalemia
Interventions: Patiromer; Drug
Lead sponsor: Vifor Pharma, Inc.; Industry
Eligibility: 0 Years to 11 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 13
States / cities: Aurora, Colorado • Jacksonville, Florida • Miami, Florida + 10 more

Conditions: Brain Injuries, Traumatic
Interventions: Standard Overground Assessment, Robotic Safety-Environment Assessment; Diagnostic Test
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Gestational Diabetes, Pregnancy Related
Interventions: Insulin; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 430 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Rochester, New York • Philadelphia, Pennsylvania

Conditions: Healthy Adults
Interventions: CoFactor, Leucovorin; Drug
Lead sponsor: Mast Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque

Residual Effects of Intoxication on Student Performance

Yoga Versus Exercises for Managing OA

Lidocaine for Oxaliplatin-induced Neuropathy

Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)

Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women

A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis

A Plant-Based Diet in the Treatment of Coronary Microvascular Dysfunction

Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics

Risk Stratification in Primary Care Combined With Stratified-specific Physical Therapy Care for Low Back Pain

Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

Investigating Central Neurophysiologic Correlates of Non-Motor Symptoms of Parkinson's Disease

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting

Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease

A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin

Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels

Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.